We are live on ! Find out more
VIVO

Meridian Bioscience Inc

Delisted

VIVO was delisted on the 30th of January, 2023.

191 hedge funds and large institutions have $657M invested in Meridian Bioscience Inc in 2020 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 65 increasing their positions, 59 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more call options, than puts

Call options by funds: $2.7M | Put options by funds: $1.65M

10% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 59

9% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 34

0% more funds holding

Funds holding: 191191 (0)

28% less capital invested

Capital invested by funds: $915M → $657M (-$258M)

100% less funds holding in top 10

Funds holding in top 10: 30 (-3)

Holders
191
Holders Change
Holders Change %
0%
% of All Funds
3.85%
Holding in Top 10
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
New
37
Increased
65
Reduced
59
Closed
34
Calls
$2.7M
Puts
$1.65M
Net Calls
+$1.05M
Net Calls Change
-$1.76M
Name Holding Trade Value Shares
Change
Change in
Stake
CSS
76
Cubist Systematic Strategies
Connecticut
$726K +$420K +21,627 +102%
SEI Investments
77
SEI Investments
Pennsylvania
$702K +$119K +6,115 +17%
SOADOR
78
State of Alaska Department of Revenue
Alaska
$681K -$5.64K -290 -0.7%
SDIC
79
South Dakota Investment Council
South Dakota
$681K
TPSF
80
Texas Permanent School Fund
Texas
$680K +$120K +6,195 +18%
Creative Planning
81
Creative Planning
Kansas
$661K +$756K +38,904 New
TRCT
82
Tower Research Capital (TRC)
New York
$642K +$625K +32,183 +572%
SO
83
STRS Ohio
Ohio
$640K +$56.4K +2,900 +8%
Thrivent Financial for Lutherans
84
Thrivent Financial for Lutherans
Minnesota
$603K -$5.46K -281 -0.8%
AIMCA
85
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$588K
JMPWA
86
JP Morgan Private Wealth Advisors
California
$579K -$102K -5,272 -13%
D.E. Shaw & Co
87
D.E. Shaw & Co
New York
$578K -$2.65M -136,560 -80%
EGM
88
Engineers Gate Manager
New York
$569K +$651K +33,488 New
COPPSERS
89
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$565K +$227K +11,700 +54%
CCM
90
Cadence Capital Management
Massachusetts
$560K +$641K +33,000 New
VOYA Investment Management
91
VOYA Investment Management
Georgia
$556K -$7.21K -371 -1%
State Board of Administration of Florida Retirement System
92
State Board of Administration of Florida Retirement System
Florida
$550K
T. Rowe Price Associates
93
T. Rowe Price Associates
Maryland
$544K +$274K +14,100 +79%
State of Tennessee, Department of Treasury
94
State of Tennessee, Department of Treasury
Tennessee
$523K +$47.8K +2,458 +9%
AG
95
Aperio Group
California
$509K +$8.67K +446 +2%
AIG
96
American International Group
New York
$497K -$14K -720 -2%
UBS Group
97
UBS Group
Switzerland
$491K -$71.6K -3,686 -11%
Citigroup
98
Citigroup
New York
$482K +$37.9K +1,948 +7%
Stifel Financial
99
Stifel Financial
Missouri
$476K +$545K +28,060 New
CI Investments Inc
100
CI Investments Inc
Ontario, Canada
$465K -$40.6K -2,088 -7%

VIVO Hedge Fund Activity: Q3 2020 in Review

191 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q3 2020, worth a combined $657M — down 28% from $915M a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new VIVO positions and 34 closed out — a net gain of 3 holders — while 65 added to existing stakes and 59 trimmed.

The largest buyer was Foundry Partners, opening a new position worth an estimated $5.61M. The largest seller was Millennium Management, cutting an estimated $12.9M.

  • 191 institutional investors held Meridian Bioscience Inc (VIVO) as of Q3 2020, unchanged from Q2 2020.
  • Funds reported $657M of Meridian Bioscience Inc stock for Q3 2020, down 28% quarter-over-quarter.
  • 37 funds opened new Meridian Bioscience Inc positions in Q3 2020 and 34 closed out, a net change of +3 holders.
  • The largest Meridian Bioscience Inc buyer in Q3 2020 was Foundry Partners, an estimated $5.61M added.
  • The largest Meridian Bioscience Inc seller in Q3 2020 was Millennium Management, an estimated $12.9M sold.

Based on aggregated 13F filings for Q3 2020.